Your browser doesn't support javascript.
loading
MiR-16 regulates crosstalk in NF-κB tolerogenic inflammatory signaling between myeloma cells and bone marrow macrophages.
Khalife, Jihane; Ghose, Jayeeta; Martella, Marianna; Viola, Domenico; Rocci, Alberto; Troadec, Estelle; Terrazas, Cesar; Satoskar, Abhay R; Gunes, Emine Gulsen; Dona, Ada; Sanchez, James F; Bergsagel, P Leif; Chesi, Marta; Pozhitkov, Alex; Rosen, Steven; Marcucci, Guido; Keats, Jonathan J; Hofmeister, Craig C; Krishnan, Amrita; Caserta, Enrico; Pichiorri, Flavia.
Afiliação
  • Khalife J; Judy and Bernard Briskin Center for Multiple Myeloma Research, Hematologic Malignancies and Stem Cell Transplantation Institute, City of Hope Medical Center, Duarte, California, USA.
  • Ghose J; Department of Hematologic Malignancies Translational Science, Beckman Research Institute, City of Hope Medical Center, Duarte, California, USA.
  • Martella M; Department of Radiation Oncology, The Ohio State University, Columbus, Ohio, USA.
  • Viola D; Judy and Bernard Briskin Center for Multiple Myeloma Research, Hematologic Malignancies and Stem Cell Transplantation Institute, City of Hope Medical Center, Duarte, California, USA.
  • Rocci A; Department of Hematologic Malignancies Translational Science, Beckman Research Institute, City of Hope Medical Center, Duarte, California, USA.
  • Troadec E; Judy and Bernard Briskin Center for Multiple Myeloma Research, Hematologic Malignancies and Stem Cell Transplantation Institute, City of Hope Medical Center, Duarte, California, USA.
  • Terrazas C; Department of Hematologic Malignancies Translational Science, Beckman Research Institute, City of Hope Medical Center, Duarte, California, USA.
  • Satoskar AR; Faculty of Biology, Medicine and Health, School of Medical Science, Division of Cancer Science, University of Manchester, Manchester, United Kingdom.
  • Gunes EG; Judy and Bernard Briskin Center for Multiple Myeloma Research, Hematologic Malignancies and Stem Cell Transplantation Institute, City of Hope Medical Center, Duarte, California, USA.
  • Dona A; Department of Hematologic Malignancies Translational Science, Beckman Research Institute, City of Hope Medical Center, Duarte, California, USA.
  • Sanchez JF; Division of Experimental Pathology, Department of Microbiology, The Ohio State University Medical Center, Columbus, Ohio, USA.
  • Bergsagel PL; Division of Experimental Pathology, Department of Microbiology, The Ohio State University Medical Center, Columbus, Ohio, USA.
  • Chesi M; Judy and Bernard Briskin Center for Multiple Myeloma Research, Hematologic Malignancies and Stem Cell Transplantation Institute, City of Hope Medical Center, Duarte, California, USA.
  • Pozhitkov A; Judy and Bernard Briskin Center for Multiple Myeloma Research, Hematologic Malignancies and Stem Cell Transplantation Institute, City of Hope Medical Center, Duarte, California, USA.
  • Rosen S; Judy and Bernard Briskin Center for Multiple Myeloma Research, Hematologic Malignancies and Stem Cell Transplantation Institute, City of Hope Medical Center, Duarte, California, USA.
  • Marcucci G; Department of Medicine, Mayo Clinic Arizona, Scottsdale, Arizona, USA.
  • Keats JJ; Department of Medicine, Mayo Clinic Arizona, Scottsdale, Arizona, USA.
  • Hofmeister CC; Department of Computational and Quantitative Medicine, Beckman Research Institute, City of Hope, Duarte, California, USA.
  • Krishnan A; Judy and Bernard Briskin Center for Multiple Myeloma Research, Hematologic Malignancies and Stem Cell Transplantation Institute, City of Hope Medical Center, Duarte, California, USA.
  • Caserta E; Department of Hematologic Malignancies Translational Science, Beckman Research Institute, City of Hope Medical Center, Duarte, California, USA.
  • Pichiorri F; Gehr Family Center for Leukemia Research, Hematologic Malignancies and Stem Cell Transplantation Institute, City of Hope, Duarte, California, USA.
JCI Insight ; 4(21)2019 11 01.
Article em En | MEDLINE | ID: mdl-31593552

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células da Medula Óssea / Transdução de Sinais / NF-kappa B / MicroRNAs / Macrófagos / Mieloma Múltiplo Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células da Medula Óssea / Transdução de Sinais / NF-kappa B / MicroRNAs / Macrófagos / Mieloma Múltiplo Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article